Business View Oceania | July 2022

53 54 BUSINESS VIEW OCEANIA VOLUME 4, ISSUE 7 BUSINESS VIEW OCEANIA VOLUME 4, ISSUE 7 CENTRE FOR COMMERCIALISATION OF REGENERATIVE MEDICINE (CCRM) AUSTRALIA C entre for Commercialisation of Regenerative Medicine (CCRM) Australia works to accelerate the commercialisation of regenerative medicine (RM) therapies and related technologies by providing specialist expertise, funding opportunities, and fostering connections between industry, clinicians, researchers, and key stakeholders throughout the country. The not-for-profit organisation was founded in 2018, based on the successful model of Canada’s Centre for Commercialisation of Regenerative Medicine (CCRM Canada), to establish a leader that would champion growth in Australia’s RM sector. CCRM Australia’s vision is to: “Enable unique translational platforms that address the key bottlenecks in RM commercialisation, integrate Australia’s strength in stem cell and biomaterials sciences with dynamic business leadership, engage industry partners and link to a global nexus of RM commercialisation, and AT A GLANCE CENTRE FOR COMMERCIALISATION OF REGENERATIVE MEDICINE (CCRM) AUSTRALIA WHAT: Not-for-profit organisation supporting regenerative medicine commercialisation in the Australian market WHERE: CCRM Australia is hosted at the Australian Regenerative Medicine Institute at Monash University in Melbourne, Australia WEBSITE: ccrmaustralia.com.au C O M M E R C I A L I S I N G L I V I N G T H E R A P I E S